PHARMACEUTICAL RAW MATERIALS AND EXCIPIENTS OPTIONS

“The current problem has exposed some structural weaknesses from the EU’s medicines provide chain plus a large dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides mentioned. She advisable that offer chain issues be addressed within an EU pharmaceutical strategy expected for being introduced by the